cfDNA Methylation for Liver Cancer Recurrence Detection

Clinical trial NCT07466602 · RECRUITING

Trial details

NCT number: NCT07466602
Sponsor: Wuhan Ammunition Life-tech Co., Ltd
Status: RECRUITING
Study type: OBSERVATIONAL

Primary Liver Cancer

Start date: 2025-09-02
Primary completion: 2027-06-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.